Diabetes due to secretion of an abnormal insulin
- PMID: 7350438
- DOI: 10.1056/NEJM198001173020301
Diabetes due to secretion of an abnormal insulin
Abstract
A 51-year-old, nonobese man with diabetes mellitus had marked hyperinsulinemia (70 to 120 muU per milliliter; 502 to 860 pmol per liter) and fasting hyperglycemia (140 to 170 mg per 100 ml; 7.8 to 9.4 mmol per liter). Plasma proinsulin, glucagon, growth hormone, and cortisol levels were normal; insulin antibodies and insulin-receptor antibodies were not detected. The patient showed relatively normal insulin sensitivity, and insulin receptors on circulating monocytes were within the normal range. Insulin from the patient's serum bound to IM-9 lymphocytes and rat adipocytes approximately 40 per cent as well as insulin standards. Its biologic activity on rat adipocytes averaged 15 per cent of that expected from its immunologic concentration. The impaired biologic activity of this patient's circulating insulin was probably due to a structural abnormality. Subsequent studies of the patient's insulin (fortuitously obtained from his pancreas during a laparotomy for a pancreatic cyst) have confirmed this conclusion. (N Engl J Med 302:129-135, 1980).
Similar articles
-
Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes.J Clin Invest. 1979 May;63(5):939-46. doi: 10.1172/JCI109394. J Clin Invest. 1979. Retraction in: Diabetes. 1980 Aug;29(8):672. doi: 10.2337/diab.29.8.672b. PMID: 376552 Free PMC article. Retracted.
-
Familial hyperinsulinemia due to a structurally abnormal insulin. Definition of an emerging new clinical syndrome.N Engl J Med. 1984 May 17;310(20):1288-94. doi: 10.1056/NEJM198405173102004. N Engl J Med. 1984. PMID: 6371526
-
Insulin-like growth factor-I improves glucose and lipid metabolism in type 2 diabetes mellitus.J Clin Invest. 1992 Dec;90(6):2234-41. doi: 10.1172/JCI116109. J Clin Invest. 1992. PMID: 1469083 Free PMC article.
-
Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.Acta Diabetol. 2009 Jun;46(2):85-95. doi: 10.1007/s00592-009-0112-9. Epub 2009 Mar 26. Acta Diabetol. 2009. PMID: 19322513 Review.
-
RECENT ADVANCES RELATIVE TO DIABETES MELLITUS.Ann Intern Med. 1965 Sep;63:512-29. doi: 10.7326/0003-4819-63-3-512. Ann Intern Med. 1965. PMID: 14327514 Review. No abstract available.
Cited by
-
A λ-Dynamics Investigation of Insulin Wakayama and Other A3 Variant Binding Affinities to the Insulin Receptor.J Chem Inf Model. 2024 Jul 22;64(14):5657-5670. doi: 10.1021/acs.jcim.4c00662. Epub 2024 Jul 4. J Chem Inf Model. 2024. PMID: 38963805 Free PMC article.
-
Insulin Wakayama: familial mutant insulin syndrome in Japan.Diabetologia. 1987 Feb;30(2):87-92. doi: 10.1007/BF00274577. Diabetologia. 1987. PMID: 3552828
-
Semisynthesis and biological properties of the [B24-leucine]-, [B25-leucine[- and [B24-leucine, B25-leucine]-analogues of human insulin.Experientia. 1981;37(8):811-3. doi: 10.1007/BF01985653. Experientia. 1981. PMID: 7026270
-
Biochemical and clinical implications of proinsulin conversion intermediates.J Clin Invest. 1985 Oct;76(4):1398-405. doi: 10.1172/JCI112116. J Clin Invest. 1985. PMID: 3902891 Free PMC article.
-
Diabetes due to secretion of a structurally abnormal insulin (insulin Wakayama). Clinical and functional characteristics of [LeuA3] insulin.J Clin Invest. 1986 Feb;77(2):514-9. doi: 10.1172/JCI112331. J Clin Invest. 1986. PMID: 3511099 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical